Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Innovation Cardiology In Vitro Diagnostics

Bringing Polygenics Into Cardiovascular Disease Diagnosis

Effective Tool To Measure Lifetime Risk Of CHD From Polygenics Technology Innovator

  • Interviews

Executive Summary

GENinCode’s mission as a clinical-genetic diagnostic company is to apply a combination of polygenics, a proprietary bioinformatics platform and AI to risk-assess and prevent cardiovascular disease. The company set a UK precedent in being the first to have a CVD commercial polygenic test implemented in the NHS and keenly awaits another milestone, US 510k clearance in 2024.

You may also be interested in...



Innovation Adoption: ‘Medtech’s Ongoing Challenge Of The Day’

UK ministers are increasingly focusing on the need to improve uptake of new technologies in the National Health Service. Ambitious programs have been launched but implementing them effectively for lasting change in a delivery system under acute stress is a challenge of a different order.

German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023

Outlook 2024: Shaping A Medtech Environment Where Technology Leads The Way

Environmental demands, the evolution of care models, new delivery technologies and AI tools are influencing how medtechs must approach innovation.

Table

View full table

Topics

Tags:
Innovation Cardiology In Vitro Diagnostics
Latest Headlines

EU Lists Its First Reference Laboratories For High-Risk IVDs Falling Into Class D

German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023

Mosie Baby First To Win FDA Clearance For At-Home Artificial Insemination Kit

“We’re A Pain-Management Company.” Nevro Adds SI Joint Surgery To SCS Business

See All
UsernamePublicRestriction

Register

MT148429

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By